Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancers.

C Mazouni; S-W Kau; D Frye; F Andre; H M Kuerer; T A Buchholz; W F Symmans; K Anderson; K R Hess; A M Gonzalez-Angulo

doi:10.1093/annonc/mdm008

Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancers.

NobleID: NI4P27W46R88S75
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/CAD7B7F2

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CAD7B7F2.svg?ark=w1%2F20260515%2FCAD7B7F2&value=id)](https://nobleid.org/work/w1/20260515/CAD7B7F2)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancers.

NobleID: NI4P27W46R88S75
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/CAD7B7F2

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CAD7B7F2.svg?ark=w1%2F20260515%2FCAD7B7F2&value=id)](https://nobleid.org/work/w1/20260515/CAD7B7F2)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work